Table 3.

Multivariate Logistic Regression Analyses for the Association between Longer Hospital Stay (≥19 Days) and the Time to Initiation of Dapagliflozin Treatment after Hospital Admission.

	Early initiation of dapagliflozin (≤6 days)			Time from admission to initiation of dapagliflozin (per 1-day increase)
	Odds ratio	95% CI	p value	Odds ratio	95% CI	p value
Model 1	0.28	0.12-0.66	0.003	1.19	1.06-1.32	<0.001
Model 2	0.33	0.15-0.74	0.007	1.16	1.05-1.28	<0.001
Model 3	0.28	0.12-0.66	0.003	1.18	1.06-1.32	<0.001

CI: confidence interval

Model 1: Age; sex, New York Heart Association class ≥III, natural log of N-terminal pro-brain natriuretic peptide level at admission, estimated glomerular filtration rate at admission

Model 2: Age; sex, HF type (de novo AHF or worsening HF)

Model 3: Age; sex, New York Heart Association class ≥III, natural log of N-terminal pro-brain natriuretic peptide level at admission, estimated glomerular filtration rate at admission, HF type (de novo AHF or worsening HF)